Abstract
Peripheral neuropathies are the most frequent neurological complications associated with HIV, within which HIV sensory neuropathy (SN) is the most common form, which affects 30-50% of HIV/acquired immunodeficiency syndrome (AIDS) patients. HIV SN is frequently manifested with hard-to-manage pain and is often under-diagnosed and/or under-treated. Tat, trans-activator of transcription, is a key activator of HIV transcription. Despite that recent studies have highlighted the role of HIV Tat in the pathophysiology of HIV-associated neurocognitive disorders (HANDs), the involvement of HIV Tat in neuropathic pain associated with HIV SN has not been extensively investigated. Our preliminary data showed that both single and repeated intrathecal injection(s) of HIV Tat induced mechanical hypersensitivity. In the current study, we further examined pain and functional related behavioral changes in doxycycline inducible HIV-1 Tat transgenic (iTat Tg) mice following the induction of Tat expression. Two induction regimen were compared: 7-day daily injection vs. 21-day daily injection of doxycycline (i.p. at 100mg/kg). Sensory sensitivities (mechanical, heat and cold) were assessed to evaluate pain-like behaviors. Sensory (pin prick assay) and motor (hind limb grip strength, toe spread reflex and toe spacing score) functional tests were used to evaluate hind paw functions associated with Tat expression. Both regimens induced significant mechanical hypersensitivity and significant reduction of grip strength from day 3 post the initiation of Tat induction to the end of the experiment (day 35) in iTat Tg mice. Tat induction for 21 days also significantly induced cold hypersensitivity in iTat Tg mice up to day 14 post-the first doxycycline injection. Neither regimen induced significant heat hypersensitivity or affected other functional measurements. Together, our results suggest the utility of iTat Tg mice in studying the role of Tat in HIV SN. Sex-depended differences and Tat-induced molecular pathways will be further investigated in future studies. (Grant support: R21 DA044886 [PI Cao])
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.